NERV CIK: 1598646

Minerva Neurosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
millions USD
FY21:
–
FY22:
–
FY23:
–
FY24:
–
FY25:
–
(positive)
Change from FY21 to FY25
millions USD
FY21:
−45.4
FY22:
−25.2
FY23:
−23.1
FY24:
−21.8
FY25:
−15.1
(positive)
Change from FY21 to FY25
millions USD
FY21:
−45.2
FY22:
−24.7
FY23:
−21.7
FY24:
4.75
FY25:
−340
(positive)
Change from FY21 to FY25
millions USD
FY21:
−51.7
FY22:
−32.1
FY23:
−30.0
FY24:
1.44
FY25:
−293
(positive)
Change from FY21 to FY25
millions USD
FY21:
−49.9
FY22:
−32.1
FY23:
−30.0
FY24:
1.44
FY25:
−293

All amounts in millions USD Data sources:SEC EDGARTwelve Data